Old Web
English
Sign In
Acemap
>
authorDetail
>
Judith Kinley
Judith Kinley
Takeda Pharmaceutical Company
Medicine
Pharmacokinetics
Brentuximab vedotin
Internal medicine
Polymorphism (computer science)
3
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
2021
Expert Review of Hematology
Yuqin Song
Ye Guo
Huiqiang Huang
Wei Li
Xiaoyan Ke
Jifeng Feng
Wei Xu
Harry Miao
Judith Kinley
Gregory Song
Yi Dai
Hui Wang
Jun Zhu
Show All
Source
Cite
Save
Citations (0)
Population Pharmacokinetics of Brentuximab Vedotin in Adult and Pediatric Patients With Relapsed/Refractory Hematologic Malignancies: Model-Informed Hypothesis Generation for Pediatric Dosing Regimens.
2020
The Journal of Clinical Pharmacology
Ajit Suri
Diane R. Mould
Gregory Song
Judith Kinley
Karthik Venkatakrishnan
Show All
Source
Cite
Save
Citations (2)
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent
2013
European Journal of Clinical Pharmacology
Frances Stringer
Graham Scott
Marian Valbuena
Judith Kinley
Mitsuhiro Nishihara
Richard Urquhart
Show All
Source
Cite
Save
Citations (13)
1